Please Wait.....
Report
Epidemic keratoconjunctivitis (EKC)-Epidemiology Forecast-2032
Market Report I 2022-08-01 I 40 Pages I DelveInsight
DelveInsight's 'Epidemic keratoconjunctivitis (EKC)-Epidemiology Forecast-2032' report delivers an in-depth understanding of the EKC, historical and forecasted epidemiology as well as the EKC trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
Epidemic keratoconjunctivitis (EKC) Disease Understanding
Keratoconjunctivitis is when the patient has both keratitis and conjunctivitis simultaneously. Keratitis is inflammation of the cornea, the clear dome covering the iris and the pupil. Conjunctivitis is inflammation of the conjunctiva.
Epidemic keratoconjunctivitis (EKC) is a highly contagious viral conjunctivitis. It is caused by a group of viruses known as adenoviruses that, in addition to ocular surface infections, are responsible for causing infectious diseases of the gastrointestinal tract and respiratory system illnesses such as the common cold virus. EKC has a long incubation period and is highly contagious, leading to large outbreaks worldwide. It easily spreads where people are in close quarters, like schools, hospitals, and even doctors' offices.
The disease pathology includes the inflammation of the conjunctiva (conjunctivitis) and the cornea (keratitis). Two dilemmas are associated with this disease, first is that the virus in the early stage of incubation is asymptomatic, which leads to easy direct spread to other humans in contact; second, to date, no treatment exists with approved effect against EKC.
The adenovirus pathogen causes EKC. Adenoviral conjunctivitis is the most common cause of red-eye in the world. A study at the Wills Eye Hospital emergency room found a 62% prevalence of adenoviral conjunctivitis amongst all patients presenting with a clinical diagnosis of infectious conjunctivitis, while various other studies have demonstrated a prevalence of between 15% and 70% of all conjunctivitis worldwide.
Continued in the report..
Epidemic keratoconjunctivitis Epidemiology Perspective by DelveInsight
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Cases of Viral conjunctivitis, Total Adenovirus D-specific Incident Cases, Total Incident Cases of Epidemic keratoconjunctivitis (EKC), and Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) scenario in the 7MM covering the United States, EU-5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.
EKC Detailed Epidemiology Segmentation
- In 2021, the total incident cases of EKC in the 7MM were found to be 1,820,868. These cases are expected to go down during the study period 2019-2032.
- The highest number of cases for EKC was recorded in Japan in 2021 with a total count of 999,087 cases.
- There were 7,339,945 cases of viral conjunctivitis in the 7MM in 2021. This number of viral conjunctivitis cases is anticipated to increase during the study period.
- There were a total of 597,035 diagnosed cases of EKC in the 7MM in 2021. This total number of diagnosed cases of EKC in the 7MM is anticipated to increase during the study period.
- Japan had the highest number of diagnosed EKC cases (501,522 cases) whereas there were 58,033 diagnosed cases of EKC in the United States in 2021.
Scope of the Report
- The report covers the descriptive overview of EKC, explaining its causes, symptoms, pathophysiology, and genetic basis.
- The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU-5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The report assesses the disease risk and burden and highlights the unmet needs of Epidemic keratoconjunctivitis.
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
- The report provides the segmentation of the disease epidemiology for 7MM by Total Incident Cases of Viral conjunctivitis, Total Adenovirus D-specific Incident Cases, Total Incident Cases of Epidemic keratoconjunctivitis (EKC), and Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC).
Report Highlights
- 11-Year Forecast of EKC
- 7MM Coverage
- Total Incident Cases of Viral conjunctivitis
- Total Adenovirus D-specific Incident Cases
- Total Incident Cases of Epidemic keratoconjunctivitis (EKC)
- Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC)
Key Questions Answered
- What are the disease risk, and burden of EKC?
- What is the historical EKC patient pool in the United States, EU-5 (Germany, France, Italy, Spain, and the UK), and Japan?
- What would be the forecasted patient pool of EKC at the 7MM level?
- What will be the growth opportunities across the 7MM with respect to the patient population pertaining to EKC?
- Out of the above-mentioned countries, which country would have the highest prevalent population of EKC during the forecast period (2022-2032)?
- At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?
Reasons to buy
The Epidemic Keratoconjunctivitis (EKC) report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the 7MM EKC epidemiology forecast.
- The EKC epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
- The EKC epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Geographies Covered
- The United States
- EU-5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2019-2032
1. Key Insights
2. Report Introduction
3. Epidemic keratoconjunctivitis (EKC) Market Overview at a Glance
3.1. Epidemiology Share (%) Distribution of Epidemic keratoconjunctivitis (EKC) in the 7MM in 2019
3.2. Epidemiology Share (%) Distribution of Epidemic keratoconjunctivitis (EKC) in the 7MM in 2032
4. Epidemic keratoconjunctivitis (EKC) Market: Future Prospects
5. Executive Summary of Epidemic keratoconjunctivitis (EKC)
6. Key events
7. Disease Background and Overview
7.1. Introduction
7.1.1. Epidemic Keratoconjunctivitis (EKC)
7.2. Signs and Symptoms
7.3. Risk Factors and Causes
7.3.1. Adenoviruses
7.4. Pathophysiology and Pathogenesis
7.5. Diagnosis
8. Methodology
9. Epidemiology and Patient Population
9.1. Key Findings
9.2. Assumptions and Rationale
9.3. Epidemiology Scenario: 7MM
9.3.1. Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the 7MM
9.3.2. Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in the 7MM
9.4. The United States
9.4.1. Total Incident Cases of Viral conjunctivitis in the United States
9.4.2. Total Adenovirus D-specific Incident Cases in the United States
9.4.3. Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the United States
9.4.4. Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in the United States
9.5. EU-5 Epidemiology
9.5.1. Total Incident Cases of Viral conjunctivitis in EU-5
9.5.2. Total Adenovirus D-specific Incident Cases in EU-5
9.5.3. Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in EU-5
9.5.4. Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in EU-5
9.6. Japan Epidemiology
9.6.1. Total Incident Cases of Viral conjunctivitis in Japan
9.6.2. Total Adenovirus D-specific Incident Cases in Japan
9.6.3. Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in Japan
9.6.4. Total Diagnosed Cases of Epidemic keratoconjunctivitis (EKC) in Japan
10. KOL Views
11. Appendix
11.1. Report Methodology
11.2. Bibliography
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
Table 1: Summary of Epidemic keratoconjunctivitis (EKC), Epidemiology, and Key Events (2019-2032)
Table 2: Key Events
Table 3: Subtypes of Group B and D HAdV with Sites of Infection
Table 4: The differential diagnosis of EKC: Other Types of Conjunctivitis
Table 5: Universal Protection Control Procedures
Table 6: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the 7MM (2019-2032), in '000
Table 7: Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in the 7MM (2019-2032), in '000
Table 8: Total Incident Cases of Viral conjunctivitis in the United States (2019-2032), in '000
Table 9: Total Adenovirus D-specific Incident Cases in the United States in the United States (2019-2032), in '000
Table 10: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the United States (2019-2032), in '000
Table 11: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the United States (2019-2032), in '000
Table 12: Total Incident Cases of Viral conjunctivitis in EU-5(2019-2032), in '000
Table 13: Total Adenovirus D-specific Incident Cases in EU-5 (2019-2032), in '000
Table 14: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in EU-5(2019-2032), in '000
Table 15: Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in EU-5 (2019-2032), in '000
Table 16: Total Incident Cases of Viral conjunctivitis in Japan (2019-2032), in '000
Table 17: Total Adenovirus D-specific Incident Cases in Japan (2019-2032), in '000
Table 18: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in Japan(2019-2032), in '000
Table 19: Total Diagnosed Cases of Epidemic keratoconjunctivitis (EKC) in Japan (2019-2032), in '000
Figure 1: Conjunctivitis Classification
Figure 2: Types of Conjunctivitis
Figure 3: Patient with Epidemic keratoconjunctivitis
Figure 4: Signs and Symptoms of Epidemic keratoconjunctivitis
Figure 5: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the 7MM (2019-2032)
Figure 6: Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in the 7MM (2019-2032)
Figure 7: Total Incident Cases of Viral conjunctivitis in the United States (2019-2032)
Figure 8: Total Adenovirus D-specific Incident Cases in the United States (2019-2032)
Figure 9: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in the United States (2019-2032)
Figure 10: Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in the United States (2019-2032)
Figure 11: Total Incident Cases of Viral conjunctivitis in EU-5 (2019-2032)
Figure 12: Total Adenovirus D-specific Incident Cases in EU-5 (2019-2032)
Figure 13: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in EU-5 (2019-2032)
Figure 14: Total Diagnosed Incident Cases of Epidemic keratoconjunctivitis (EKC) in EU-5 (2019-2032)
Figure 15: Total Incident Cases of Viral conjunctivitis in Japan (2019-2032)
Figure 16: Total Adenovirus D-specific Incident Cases in Japan (2019-2032)
Figure 17: Total Incident Cases of Epidemic keratoconjunctivitis (EKC) in Japan (2019-2032)
Figure 18: Total Diagnosed Cases of Epidemic keratoconjunctivitis (EKC) in Japan (2019-2032)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security